Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,774,348,291
+$310,630,954 QoQ
Shares Held
9,357,390
+26.1% QoQ
Ownership
0.603%
of shares outstanding
% of Portfolio
19.39%
of 13F equity value
Holder Rank
#26
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAUSEWAY CAPITAL MANAGEMENT LLC holds $2,118,676,056 across 8 Drug Manufacturers - General names. AZN ranks #1 (83.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
9,357,390 | $1,774,348,291 | |
| 2 | MRK |
Merck & Co., Inc.
|
954,932 | $122,708,762 | |
| 3 | NVO |
Novo Nordisk A S
|
1,677,615 | $80,424,863 | |
| 4 | BIIB |
Biogen Inc.
|
278,283 | $60,125,824 | |
| 5 | PFE |
Pfizer Inc
|
1,916,801 | $46,156,568 | |
| 6 | SNY |
Sanofi
|
804,056 | $34,301,028 | |
| 7 | GSK |
GSK plc
|
7,163 | $375,484 | |
| 8 | NVS |
Novartis AG
|
1,501 | $235,236 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,774,348,291 | 9,357,390 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,463,717,337 | 7,421,749 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||